What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Psychiatry
- Neurotransmitter
John J. O'Connor mainly focuses on Long-term potentiation, Internal medicine, Endocrinology, Neuroscience and Dentate gyrus.
His study in Long-term potentiation is interdisciplinary in nature, drawing from both Synaptic plasticity, NMDA receptor, AMPA receptor, Neurotransmission and Hippocampus.
His work on Kidney disease, Renal function, Uremia and Renal blood flow is typically connected to Leptin receptor as part of general Internal medicine study, connecting several disciplines of science.
His Endocrinology research integrates issues from Degeneration, Retinal and Hemodialysis.
His biological study spans a wide range of topics, including Receptor and Metabotropic glutamate receptor.
As part of the same scientific family, he usually focuses on Dentate gyrus, concentrating on Immunology and intersecting with Neuroprotection.
His most cited work include:
- Interleukin-1β (IL-1β) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro (368 citations)
- Actions of TNF‐α on glutamatergic synaptic transmission in the central nervous system (325 citations)
- Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis (284 citations)
What are the main themes of his work throughout his whole career to date?
John J. O'Connor mostly deals with Internal medicine, Endocrinology, Long-term potentiation, Neuroscience and Dentate gyrus.
His work on Adenosine A1 receptor, Serotonin, Raphe nuclei and Dorsal raphe nucleus as part of general Internal medicine study is frequently connected to Imipramine, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His studies deal with areas such as Agonist, Receptor, Glutamate receptor and Receptor antagonist as well as Endocrinology.
His Long-term potentiation research incorporates themes from Synaptic plasticity, Neurotransmission, Excitatory postsynaptic potential, Hippocampal formation and Hippocampus.
The study incorporates disciplines such as AMPA receptor and In vitro in addition to Neuroscience.
His Dentate gyrus study combines topics from a wide range of disciplines, such as Proinflammatory cytokine and Metabotropic glutamate receptor.
He most often published in these fields:
- Internal medicine (26.90%)
- Endocrinology (25.15%)
- Long-term potentiation (19.88%)
What were the highlights of his more recent work (between 2015-2021)?
- Pharmacology (16.37%)
- Psychotherapist (4.68%)
- Dopamine (8.19%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Pharmacology, Psychotherapist, Dopamine, Hypoxia and Internal medicine.
His Pharmacology research includes elements of Nicotine, Amphetamine, Caffeine and Acetylcholine receptor.
His research integrates issues of Agonist and Nicotinic agonist in his study of Dopamine.
His Hypoxia research incorporates elements of Tumor necrosis factor alpha, Inflammation, Neuroprotection, Neurotransmission and Tissue plasminogen activator.
As part of his studies on Internal medicine, John J. O'Connor often connects relevant areas like Endocrinology.
His research in Endocrinology intersects with topics in Reactive oxygen species, Myometrium and Antagonist.
Between 2015 and 2021, his most popular works were:
- The Effects of Hypoxia and Inflammation on Synaptic Signaling in the CNS (58 citations)
- A Brain-Derived Neurotrophic Factor Mimetic Is Sufficient to Restore Cone Photoreceptor Visual Function in an Inherited Blindness Model. (15 citations)
- “Meaningless carrying-on”: A psychoanalytically-oriented qualitative study of compulsive hoarding. (6 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Psychiatry
- Neurotransmitter
John J. O'Connor focuses on Pharmacology, Dopamine, Nicotine, SCH-23390 and Nicotinic agonist.
John J. O'Connor undertakes interdisciplinary study in the fields of Pharmacology and Cyclic voltammetry through his research.
His research combines MDMA and Dopamine.
His Nicotine research is multidisciplinary, incorporating elements of Agonist, Dopamine receptor D1, Brain stimulation reward and Acetylcholine receptor.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
